系统性红斑狼疮合并血液系统恶性肿瘤的研究进展

Study progress of relationship between systemic lupus erythematosus and hematological malignancies

系统性红斑狼疮（SLE）属于自身免疫性疾病中的一种，免疫抑制剂为治疗SLE的主要药物之一，近年来较多学者研究SLE患者恶性肿瘤的发生率时发现血液系统恶性肿瘤占较大比例，并且发现其可能与免疫抑制剂使用有关。

Systemic lupus erythematosus is one kind of autoimmune diseases. Immunosuppressants are one of the main drugs for the treatment of systemic lupus erythematosus. In recent years, more scholars found that hematological malignancies had a certain proportion in malignancies when they researched the incidence of malignant tumors in systemic lupus erythematosus. At the same time, they found that it is associated with the use of immunosuppressants.